To summarize the structural organization, developmental stages, and clinical significance of tertiary lymphoid structures (TLS) in breast cancer, emphasizing their context-dependent roles.
Key Findings:
TLS are associated with both favorable and unfavorable clinical outcomes in breast cancer, reflecting their heterogeneous nature as noted in the source.
TLS maturity varies significantly across different breast cancer settings, influencing their functional roles as described in the source.
Standardized classification of TLS is necessary for better understanding and clinical application, as highlighted in the source.
Interpretation:
TLS status represents a context-dependent biomarker in breast cancer, requiring further mechanistic understanding for clinical translation.
Limitations:
Lack of standardized classification criteria for TLS across studies.
Variability in TLS maturation and immune composition complicates interpretation of their clinical significance.
Conclusion:
TLS represent a complex aspect of the tumor microenvironment in breast cancer, with implications for understanding tumor behavior.
